- Antibiotic Resistance of Acinetobacter baumannii in Iran: A Systemic Review of the Published Literature
-
Jale Moradi, Farhad B. Hashemi, Abbas Bahador
-
Osong Public Health Res Perspect. 2015;6(2):79-86. Published online April 30, 2015
-
DOI: https://doi.org/10.1016/j.phrp.2014.12.006
-
-
4,231
View
-
34
Download
-
55
Crossref
-
Abstract
PDF
- Objectives
Acinetobacter baumannii is a bacterium responsible for health care-associated infections, and it frequently develops multiple drug resistance (MDR). The prevalence of antibiotic-resistant A. baumannii in Iran has increased, and this may cause significant clinical problems. Therefore, in order to elucidate the development of antibiotic resistance, we performed a systematic review of the literature published on antibiotic-resistant A. baumannii reported in Iran. Methods
Thirty-six publications that met the criteria for inclusion were reviewed from an initial 87 papers. Selected papers published between 2008 and September 2014, were categorized on the basis of the sample collecting year been between 2001 and 2013. Results
Analysis of data revealed that, in general, there was an increase in antimicrobial resistance. During the initial time point of these studies (2001–2007) there was a high rate of resistance to all antibiotics, with the exception of carbapenems, lipopeptides, and aminoglycosides that had a low resistance rate in comparison with the others. Also, the resistance rate was increased in one group of these three antimicrobial groups from 2010 to 2013. In particular, there was an increase in resistance to carbapenems (imipenem and meropenem) from 2010–2011 and 2012–2013, whereas no significant change in the resistance rate of the other two antimicrobial groups (lipopeptides and aminoglycosides) during the study time was observed, although we did observe certain trends in amikacin (aminoglycoside group antibiotic) between 2011–2012 and 2012–2013. Conclusion
These findings indicate that antimicrobial resistance of A. baumannii in Iran has increased, which may very well affect the antimicrobial resistance of this organism worldwide. Based on these results, novel prevention and treatment strategies against A. baumannii infections are warranted. Furthermore, these data may assist in revising treatment guidelines and regional policies in care units to slow the emergence of antimicrobial resistance.
-
Citations
Citations to this article as recorded by 
- Evaluation of Mycobacterium tuberculosis Early Secreted Antigenic Target 6 Recombinant Protein as a Diagnostic Marker in Skin Test
-
Jale Moradi, Nader Mosavari, Mahmoud Ebrahimi, Reza Arefpajohi, Majid Tebianian
-
Osong Public Health Res Perspect. 2015;6(1):34-38. Published online February 28, 2015
-
DOI: https://doi.org/10.1016/j.phrp.2014.12.002
-
-
3,514
View
-
21
Download
-
5
Crossref
-
Abstract
PDF
- Objectives
Tuberculosis (TB) is the leading infectious disease in the developing world. Delayed-type hypersensitivity skin test diagnoses TB using tuberculin purified protein derivative (PPD), but this test is incapable of distinguishing Mycobacterium tuberculosis (MTB) infection from bacillus Calmette–Guérin (BCG) vaccination or an infection caused by nontuberculous mycobacteria (NTM). This study was performed to evaluate the use of recombinant early secretory antigenic target 6 (rESAT-6), a secretory protein found only in MTB, Mycobacterium bovis, and few other mycobacterial species, as a skin marker for MTB in guinea pigs. Methods
We prepared recombinant MTB ESAT-6 and evaluated its use as a specific antigen for MTB in guinea pigs. Results
Our results show that the purified MTB rESAT-6 antigen is capable of inducing a positive reaction only in guinea pigs sensitized to MTB. No such reaction was observed in the animals sensitized to M. bovis, BCG vaccination, or NTM (Mycobacterium avium). Conclusion
Our study results confirm that the ESAT-6 antigen is more specific to MTB infection than PPD and could be used in more specific skin tests for detection of MTB in large animals and in humans.
-
Citations
Citations to this article as recorded by 
- Biological evaluation of mimetic peptides as active molecules for a new and simple skin test in an animal model
Deborah Carbonera Guedes, Aline Kuhn Sbruzzi Pasquali, João Carlos Minozzo, Craig Faulds, Ricardo Rasmussen Petterle, Carlos Ricardo Soccol, Vanete Thomaz Soccol Parasitology Research.2019; 118(1): 317. CrossRef - Application of transdermal patches with new skin test reagents for detection of latent tuberculosis
Songsri Kasempimolporn, Pannatat Areekul, Wichit Thaveekarn, Rattana Sutthisri, Supatsorn Boonchang, Artikaya Sawangvaree, Visith Sitprija Journal of Medical Microbiology.2019; 68(9): 1314. CrossRef - Guinea pig infected with Mycobacterium tuberculosis via oral consumption
Jianfeng Gao, Ming Guo, Li Teng, Rong Bao, Qiaoyang Xian, Xin Wang, Wenzhe Ho Journal of Applied Animal Research.2018; 46(1): 1323. CrossRef - New strategy to improve quality control of Montenegro skin test at the production level
Deborah Carbonera Guedes, João Carlos Minozzo, Aline Kuhn Sbruzzi Pasquali, Craig Faulds, Carlos Ricardo Soccol, Vanete Thomaz-Soccol Revista da Sociedade Brasileira de Medicina Tropic.2017; 50(6): 788. CrossRef - Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane
Laura Chiaradia, Cyril Lefebvre, Julien Parra, Julien Marcoux, Odile Burlet-Schiltz, Gilles Etienne, Maryelle Tropis, Mamadou Daffé Scientific Reports.2017;[Epub] CrossRef
|